Anticancer drugs
5-FU	5-fluorouracil
ADM	adriamycin
AMF	amonafide
BTZ	bortezomib
CARB	carboplatin
CDDP	cisplatin
CLB	chlorambucil
ConA	concanavalin A
DHA	docosahexaenoic acid
DOX	doxorubicin
DTX	docetaxel
GEM	gemcitabine
MTX	methotrexate
PDX	podophyllotoxin
PTX	paclitaxel
Cell lines
4T1	murine breast cancer cell line
A375	human melanoma cell line
A549	human pulmonary adenocarcinoma cell line
A2780	epithelial ovarian cancer cell line
A2780/CP	CDDP-resistant subline
AsPC-1	human pancreas adenocarcinoma
B16-F1	mouse melanoma cell line
B16-F10	mouse melanoma cell line
BJ-H-tert RPMI	normal fibroblasts
C26	murine colorectal carcinoma cell line
Calu-3	human lung cancer cell line
C57BL6	mice melanoma cell line
CEM	T-lymphoblastic leukemia cell line
Colo-205	colorectal adenocarcinoma
CT26	mouse colon adenocarcinoma cell line
DLD-1	colorectal adenocarcinoma cell line
G 361	malignant melanoma cell line
H1299	human non-small lung carcinoma cell line
HaCaT	keratinocyte cancer cell line
HCT-116	human colon carcinoma cell line
HeLa	human cervical cancer cell line
HepG2	human hepatocellular carcinoma cell line
HL-60	human promyelocytic leukemia cell line
HTB-177	lung cancer cell line
HUVEC	human umbilical vein endothelial
Hs683	human brain glioma cell line
K-562	human chronic myelogenous leukaemia
MCF-7	human breast cancer cell line
MDA-MB-231	human breast cancer cell line
NCI-H460	lung cancer cell line
CD44-	fibroblast cell line
NKE	normal kidney epithelial cell line
OVCAR-3	ovarian carcinoma cell line
OVCAR-8	ovarian carcinoma cell line
PANC-1	human pancreas ductal adenocarcinoma
PC-3	human prostate cancer cell line
RPMI 8226	multiple myeloma cell line
22Rv1	human prostate carcinoma cell line
Saos-2	human osteosarcoma cell line
SHY5Y	hyman neuroblastoma cell line
SK-Hep-1	human hepatic adenocarcinoma
SGC-790	endocervical adenocarcinoma
U-251	human glioblastoma cell line
WS1	normal skin fibroblasts
VMCF-7	human breast cancer
XHepG2	human liver cancer cell line